SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration on December 6, 2022, for use of the ...
Therefore, we collected serum samples from participants who had received three doses of either of the original monovalent mRNA vaccines followed by one dose of a bivalent vaccine targeting BA.4–BA.5 ...
Imagine the last time you went to the doctor feeling miserable with a cold. If you have ever heard “you have a virus” from your physician, you know exactly what that means. There are no antibiotics ...
SAN DIEGO--(BUSINESS WIRE)--AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today ...
In a recent study published in Frontiers, researchers investigated the transmission- and immunoglobulin G (IgG) viral neutralization potential of coronavirus disease 2019 (COVID-19) booster vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results